Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies a high risk subgroup with inferior survival
Maybury, Bernard D James, Lisa J Phillips, Neil Venkatadasari, Indrani Qureshi, Iman Riley, James Talbot, Georgina Moosai, Shivir Giles, Hannah Chadderton, Nicola
Maybury, Bernard D
James, Lisa J
Phillips, Neil
Venkatadasari, Indrani
Qureshi, Iman
Riley, James
Talbot, Georgina
Moosai, Shivir
Giles, Hannah
Chadderton, Nicola
Abstract
A reciprocal t(3;8) BCL6::MYC fusion is common in large B cell lymphoma (LBCL) with MYC and BCL6 disruption. These pseudo-double hit cases are not adverse, whereas t(3;8) negative MYC/BCL6 lymphoma has an inferior prognosis relative to other MYC-rearranged LBCL.
MIDER Authors
Gonzalez, Monica Vega
Maybury, Bernard Douglas
James, Lisa Jane
Giles, Hannah Victoria
Chadderton, Nicola
Dowds, James
Crosland, Henry
Haslam, Aidan
Rudzki, Zbigniew
Chaganti, Sridhar
Maybury, Bernard Douglas
James, Lisa Jane
Giles, Hannah Victoria
Chadderton, Nicola
Dowds, James
Crosland, Henry
Haslam, Aidan
Rudzki, Zbigniew
Chaganti, Sridhar
Maybury, Bernard Douglas
James, Lisa Jane
Giles, Hannah Victoria
Chadderton, Nicola
Dowds, James
Crosland, Henry
Haslam, Aidan
Rudzki, Zbigniew
Chaganti, Sridhar
Maybury, Bernard Douglas
James, Lisa Jane
Giles, Hannah Victoria
Chadderton, Nicola
Dowds, James
Crosland, Henry
Haslam, Aidan
Rudzki, Zbigniew
Chaganti, Sridhar
Affiliations
University Hospitals Birmingham NHS Foundation Trust; University Hospitals of the North Midlands NHS Trust; The Royal Wolverhampton NHS Trust; University Hospitals Coventry and Warwickshire NHS Foundation Trust; The Dudley Group NHS Foundation Trust; Shrewsbury and Telford Hospital NHS Trust; Walsall Healthcare NHS Trust; Sandwell and West Birmingham Hospitals NHS Trust
Citations
Altmetric:
Date
2024-07-04
Type
Article
Subject
Citation
Maybury BD, James LJ BSc (Hons), Phillips N, Venkatadasari I, Qureshi I, Riley JWE, Talbot G, Moosai S, Giles HV Dr, Chadderton N Mrs, Dowds J, Rakesh P, Crosland H, Haslam A, Lane S, Vega Gonzalez M, Davies D, Cherian G, Shenouda A, Kaudlay Sathyanarayana PK, Starczynski J, Rudzki Z, Chaganti S. Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies a high risk subgroup with inferior survival. Blood. 2024 Apr 22:blood.2024024048.